One Of Imperial’s Youngest Msc Students, An Ex-Firefighter And An Oxford Biochemist Are Building A Trust Layer For The Online Peptide Market

If you have spent any time around fitness or biohacking content lately, you have heard the claims about peptides: faster recovery, fat loss, better sleep, sharper focus. Influencers talk about them constantly, and sooner or later a lot of the people watching start to wonder about trying them. The question is always the same. Where do you actually buy?

That is where you walk into the Wild West. A typical route looks like this: a dropshipper buys product from an unverified overseas supplier, ships it through a clean, professional-looking website, adds a “for research purposes only” banner to stay on the right side of the rules, and to place an order you simply tick a box confirming you are a researcher.

Nobody checks. What arrives in the post might be exactly what the label says. It might be underdosed, mislabelled, or something else entirely. Most buyers have no way of telling.

Sam Human knew all of this. One of the youngest students on Imperial College London’s MSc in Innovation, Entrepreneurship and Management, he did the sensible thing and researched carefully before buying. He picked the best-looking supplier he could find and checked their certificates of analysis.

The website had been running for seven years, older than the peptide boom itself, which made it look about as legitimate as these things get. He stayed with them for around eight months.

Then Sophie Kitchen, an Oxford-trained biochemist, looked at one of those certificates properly. Within minutes she said it was physically impossible. The peak timings on the analysis could not have come from a real test of the compound it claimed to certify. A careful customer had read the document as proof. A scientist read the same document and said it never happened.

That gap, between what an ordinary buyer sees and what a trained scientist sees, is the reason PeptideScanner exists. It works as an independent comparison and verification platform for the online peptide market, something like a Skyscanner for a category that has never had one.

It brings vendor claims, third-party testing, reviews and educational context into one place, and scores suppliers against a transparent methodology rather than asking buyers to take marketing copy on trust. It does not sell peptides, give medical advice or encourage their use. Its founders are clear that the products it tracks are sold for research purposes, and that the job is transparency, not promotion.

How To Check A Supplier Before You Trust Them

Ask Sophie what a buyer should look at before trusting any supplier and the checklist is short and practical.

Start with the website’s age. A domain that has only existed for a few months is a very different prospect from one with a long track record, and it takes seconds to look up.

Then look at the certificates. They should be verified by an independent, accredited third-party lab, not self-issued by the seller. If you cannot tell who ran the test, treat the result as marketing rather than proof.

Finally, check that the certificate is fresh, ideally under around two months old. This is the check most people miss. Peptide batches typically sell out within one to three months, so a certificate older than that physically cannot correspond to the batch currently being shipped. An old certificate on a current product usually means the seller restocked without testing the new batch at all.

Her rule of thumb is blunt: no identifiable third-party lab, or a stale certificate that cannot match the batch, means do not buy.

The People Behind It

What makes the company worth writing about is not only the problem it has picked. It is the three people who took it on, none of whom arrived by the usual route.

An Ex-Firefighter Who Learned To Trust Himself Under Pressure

Jack Fossick, co-founder, did not come from a startup background. Singaporean and British, he left Singapore at ten and returned at eighteen for compulsory national service. He was, by his own account, medically obese and unfit when he arrived. He got fit during basic training, earned a place at command school, and trained for six months as a junior officer, qualifying as a section commander at the rank of sergeant. Only then was he posted to Brani Marine Fire Station.

He points to the whole of it, two years he had not chosen, as the thing that taught him he could handle pressure and keep going. Running a company is a different kind of pressure, he says, but knowing he can hold himself together when it counts has carried across. So has a less glamorous skill: getting a tired team to keep moving when none of them feels like it.

One night shows what the job asked of him. He was nineteen, called to a large fire on Kusu Island, where shrines were burning on a hilltop and several stations were brought in. It was Ramadan, and much of his crew had not eaten or drunk all day. Jack, who normally fasted alongside them out of solidarity, had eaten before the call, so when the alarm went he was among the first on the scene.

That meant sizing up the situation and reporting back to the operations centre before the rest arrived. He spent the rest of the night running the triage point, tracking equipment and people and delegating to the firefighters in his section, in the rain and the dark, until the fire was out at around six in the morning.

The idea for PeptideScanner came from a piece of theory he could not stop thinking about. Watching the peptide boom, he became convinced the market had reached the point where its early enthusiasts give way to a more cautious mainstream, and where trust, rather than hype, starts to decide who wins. The market did not need another vendor. It needed a layer of accountability sitting above all of them.

A Nineteen-Year-Old Obsessed With Human Potential

Jack took that thought to Sam, a coursemate on the same Imperial MSc. Sam finished school at fourteen, completed a business degree at eighteen, and was offered his place at Imperial before he turned nineteen. Since around the age of twelve he has been fixated on one question: how far human potential can be pushed. He trained himself to read at roughly 800 words a minute and once memorised about 150 Turkish words in an hour.

He later built a recruitment agency on an unfashionable belief, that far more people can perform at a high level than society assumes, if you train them properly.

That was one of several ventures he ran before PeptideScanner, across recruitment, education and apps. Some worked and some did not, usually because of timing or product-market fit. This one felt different. With earlier ideas he often had to convince people why they mattered; with this one, he says, the reaction is immediate, and users, researchers and investors tend to grasp the problem the moment it is described.

Jack’s first pitch to him was actually about selling peptides together. They quickly talked each other out of it. The more interesting and more useful opportunity, they decided, was not to add one more supplier to a confusing market, but to build the trust layer above it. At PeptideScanner, Sam now runs growth and the public-facing side, and describes the job plainly: make the market demand transparency.

That means building awareness, working with influencers, and putting pressure on suppliers until openness stops being optional. The platform, in his words, is not just a website but a pressure system for an entire market.

The Scientist Who Anchors It

The credibility of any trust platform depends on whoever signs off the science, and at PeptideScanner that is Sophie Kitchen, its Science Lead. An Oxford biochemist with a background in molecular and cellular biochemistry, a placement at the Monash Institute of Pharmaceutical Sciences and a Pergamon Press Prize to her name, she owns the testing methodology, the review of certificates, the relationships with labs and the interpretation of results.

She was the one who spotted the impossible certificate, and her job is to make sure that what PeptideScanner tells people is true and defensible, in a market that has rarely had to meet that standard.

What Comes Next

The hard part of the company, the founders agree, is not the code. Anyone can build a comparison site. The slow, genuinely defensible work is building credibility: relationships with serious institutions, standing with researchers at universities like Oxford and Imperial, and enough public trust that suppliers feel they have to be open.

There have been early signs it is landing. A pitch at an Oxbridge hackathon drew researchers and other experienced people who offered to help, and the team has begun raising early backing from angel investors.

The next milestone takes the idea from argument to evidence: an independent lab-testing programme, starting in the UK, in which PeptideScanner buys real products from the market, tests them and publishes what is genuine and what is not. After that, the founders are looking at the larger US market, bigger supplier relationships and a push to bring the whole question of peptide quality into the mainstream.

For Jack, the motivation underneath all of it predates the business. He believes in harm reduction rather than prohibition: people who are going to do something will do it, and the responsible move is to make sure they can do it with good information rather than in the dark. For Sam, it is the same instinct aimed at a bigger horizon. Peptides may become one of the next major tools in medicine and human performance, but that future cannot arrive properly while the market runs on anonymous claims and certificates no one checks.

The founders’ message to anyone tempted by what they see online is simple. If you are going to buy peptides anyway, check the supplier on peptidescanner.co first.

—TechRound does not recommend or endorse any financial, investment, trading or other advice, practices, companies, operators, health practices and providers. All articles are purely informational—